相关实验视频
Updated: Feb 13, 2026

08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
5.5K
针对膀癌,使用非活化泌尿病原体E. 大肠杆菌:一种新的BCG免疫疗法替代方案
Vladimir Yutkin1, Naseem Maalouf2,3, Chamutal Gur4,5
1Department of Urology, Hadassah Hebrew University Medical School, Jerusalem 91120, Israel.
Cells
|February 12, 2026
概括
无活化泌尿病原性大肠杆菌 (UPEC) 是一种新型免疫疗法,用于治疗非肌肉侵入性膀癌 (NMIBC). 与Bacillus Calmette-Guérin (BCG) 相比,这种膀癌治疗显示出更高的疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 超过90%的膀癌是尿癌 (UC),其中75%呈现为非肌肉侵入性膀癌 (NMIBC).
- 卡尔梅特-盖林菌 (BCG) 是标准的NMIBC免疫疗法,但有效性,复发率和毒性有限.
- 迫切需要更安全,更有效的膀癌治疗方法.
研究的目的:
- 为了研究非活化泌尿病原性大肠杆菌 (UPEC) 作为NMIBC的静脉内免疫治疗剂的潜力.
- 在临床前膀癌模型中,评估UPEC与BCG相比的疗效,特异性,免疫依赖性和安全性.
主要方法:
- 在小鼠 (MB49-luc) 和大鼠 (AY-27) 中建立了正位素膀癌模型.
- 用甲失活的UPEC菌株,包括1型菌突变菌,被静脉注射.
- 评估了疗效,存活率,免疫依赖 (T细胞) 和安全性,并与BCG进行了比较.
主要成果:
- 肠道UPEC显著降低了瘤负担,并改善了小鼠模型的存活率,表现优于BCG.
- 在大鼠中,UPEC的疗效与BCG相当,但毒性显著降低.
- 抗瘤效应依赖于T细胞,其中1型膜有助于瘤粘附;系统性UPEC给药无效,死亡率增加.
结论:
- 无活化UPEC是一种强大的,瘤向的,T细胞依赖的免疫治疗药物,用于膀癌.
- 与目前的BCG免疫疗法相比,UPEC提供了更高的安全性.
- 肠道UPEC是NMIBC治疗的有希望和实用的替代方案.
相关概念视频
X-Inactivation
42.7K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.7K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Alternative RNA Splicing
25.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.3K
Alternative RNA Splicing
5.2K
5.2K
Activation and Inactivation of G Proteins
11.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.7K

